Proqr Therapeutics N V Asset Turnover Ratio (PRQR), as of fourth quarter 2025, current and historic results, rankings and more - CSIMarket
CSIMarket
 


Proqr Therapeutics N v   (NASDAQ: PRQR)
 

Proqr Therapeutics N V Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Proqr Therapeutics N V 's asset turnover ratio has remained unchanged compare to previous quarter at 0.23 in the fourth quarter (Dec 31 2025)

Within sector 161 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the fourth quarter 2025 compared to the preceding quarter from 0 to 3277.

Asset Turnover Ratio Definition



PRQR Asset Turnover Ratio (Dec 31 2025)
IV. Quarter
0
III. Quarter
0
II. Quarter
0
I. Quarter
(Dec 31 2024)
IV. Quarter
Y / Y Asset Change -25.19 % -22.43 % -33.45 % -32.87 % 14.82 %
Y / Y Revenue Change -15.86 % -20.24 % -36.27 % -1.53 % -
Asset Turnover Ratio (TTM) 0.23 0.23 0.22 0.22 0.2
PRQR's Total Ranking # 3277 # 0 # # #
Seq. Asset Change -10.06 % 15.55 % 0 % -28.01 % -6.74 %
Seq. Revenue Change 428.98 % -22.15 % -9.06 % -77.53 % 401.48 %



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 162
Healthcare Sector # 473
Overall Market # 3277

Asset Turnover Ratio Statistics
High Average Low
0.14 0.13 0.11
(Dec 31 2025)   (Dec 31 2024)







Companies with similar Asset Turnover Ratio for the quarter ending Dec 31 2025, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Dec 31 2025 Assets at quarter ending Dec 31 2025
Vsee Health Inc   0.63 $ 12.448  Millions$ 19.681  Millions
Castle Biosciences Inc   0.63 $ 344.229  Millions$ 546.947  Millions
Sarepta Therapeutics Inc   0.63 $ 2,198.237  Millions$ 3,497.085  Millions
Eli Lilly And Company  0.62 $ 65,179.000  Millions$ 104,430.700  Millions
Cormedix Inc   0.62 $ 303.837  Millions$ 487.112  Millions
Immucell Corporation  0.62 $ 27.445  Millions$ 44.104  Millions
Halozyme Therapeutics Inc   0.62 $ 1,396.611  Millions$ 2,249.247  Millions
Twist Bioscience Corporation  0.62 $ 391.557  Millions$ 630.736  Millions
Establishment Labs Holdings Inc   0.62 $ 210.308  Millions$ 339.774  Millions
Vericel Corporation  0.61 $ 276.259  Millions$ 450.359  Millions
Fresenius Medical Care Ag  0.61 $ 22,191.391  Millions$ 36,384.338  Millions
Auna S a   0.60 $ 1,328.745  Millions$ 2,211.313  Millions
Procept Biorobotics Corporation  0.60 $ 307.226  Millions$ 513.013  Millions
Anika Therapeutics Inc   0.60 $ 112.807  Millions$ 189.499  Millions
Legend Biotech Corporation  0.59 $ 1,028.900  Millions$ 1,733.700  Millions
Conmed Corporation  0.59 $ 1,374.724  Millions$ 2,318.595  Millions
Smith and Nephew Plc  0.59 $ 6,164.000  Millions$ 10,457.000  Millions
Clearpoint Neuro Inc   0.59 $ 36.971  Millions$ 62.761  Millions
Globus Medical Inc   0.59 $ 2,938.931  Millions$ 5,017.660  Millions
Merit Medical Systems Inc  0.58 $ 1,515.270  Millions$ 2,592.735  Millions
Catalyst Pharmaceuticals Inc   0.58 $ 588.989  Millions$ 1,009.092  Millions
Liquidia Corporation  0.58 $ 158.320  Millions$ 272.189  Millions
Allurion Technologies Inc   0.58 $ 14.571  Millions$ 25.124  Millions
Solventum Corporation  0.58 $ 8,325.000  Millions$ 14,467.000  Millions
Radnet Inc   0.57 $ 2,040.210  Millions$ 3,568.768  Millions
Iqvia Holdings Inc   0.57 $ 16,310.000  Millions$ 28,656.250  Millions
Steris Plc  0.57 $ 5,828.131  Millions$ 10,277.331  Millions
Agilent Technologies inc   0.57 $ 7,065.000  Millions$ 12,459.500  Millions
Novocure Limited  0.56 $ 655.353  Millions$ 1,165.051  Millions
Exact Sciences Corporation  0.56 $ 3,245.310  Millions$ 5,817.269  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.